Drug developer ADARx seeks $1.74 billion valuation in US IPO

Technology By Reuters • September 21, 2026, 8:22 PM UTC
⏱ 1 min read 👁 4 views
Direct Source Verification: This story is aggregated from Reuters (reuters.com). Full reporting rights and copyright belong to the primary publisher.
Read on Reuters ↗
Drug developer ADARx seeks $1.74 billion valuation in US IPO  Reuters
Drug developer ADARx seeks $1.74 billion valuation in US IPO  Reuters
Original Source
https://news.google.com/rss/articles/CBMiygFBVV95cUxOUDdGZzVQcUgxaHgwWVV5Z1h2Z3NrdFZYYjVNdnhxX0tzb0NKUEs0RXZVeEdCMHEybkJvRWNpWllYWEtzcmhlQXVwQzB5MzJfUGppNkR3Snd6cXF6MXk4aUEwQ3JHWlBQY1NTRm9YVmVHeFdQdVF0RmdQNG5tbWZyb1J2cUVFVklrNVVTUmxKWjQxcncxalQyR0ExX0FwQW45S1dZX2FSazhXbnBxaWVHRVlqd3FLYzVWSVYxRHFnZGpWcXBOb1pHYnRR?oc=5
Visit Reuters ↗
SHARE STORY:
𝕏 f in

Related Coverage in Technology